nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—HTR2B—cardial valve—dilated cardiomyopathy	0.0506	0.517	CbGeAlD
Pramipexole—HTR2A—pulmonary artery—dilated cardiomyopathy	0.0109	0.112	CbGeAlD
Pramipexole—HTR2A—sympathetic nervous system—dilated cardiomyopathy	0.0106	0.109	CbGeAlD
Pramipexole—DRD4—heart—dilated cardiomyopathy	0.00761	0.0777	CbGeAlD
Pramipexole—ADRA2C—cardiac ventricle—dilated cardiomyopathy	0.00335	0.0342	CbGeAlD
Pramipexole—ADRA2C—myocardium—dilated cardiomyopathy	0.00315	0.0322	CbGeAlD
Pramipexole—HTR2B—heart—dilated cardiomyopathy	0.0028	0.0286	CbGeAlD
Pramipexole—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.00258	0.00492	CcSEcCtD
Pramipexole—Endocrine disorder—Lisinopril—dilated cardiomyopathy	0.00254	0.00485	CcSEcCtD
Pramipexole—Bladder pain—Furosemide—dilated cardiomyopathy	0.00254	0.00485	CcSEcCtD
Pramipexole—Breast pain—Lisinopril—dilated cardiomyopathy	0.00241	0.00461	CcSEcCtD
Pramipexole—Proteinuria—Lisinopril—dilated cardiomyopathy	0.00239	0.00458	CcSEcCtD
Pramipexole—Accidental injury—Lisinopril—dilated cardiomyopathy	0.00238	0.00454	CcSEcCtD
Pramipexole—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.00238	0.00454	CcSEcCtD
Pramipexole—Protein urine present—Lisinopril—dilated cardiomyopathy	0.00236	0.00451	CcSEcCtD
Pramipexole—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00235	0.00449	CcSEcCtD
Pramipexole—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00234	0.00447	CcSEcCtD
Pramipexole—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.00233	0.00445	CcSEcCtD
Pramipexole—Viral infection—Lisinopril—dilated cardiomyopathy	0.00233	0.00445	CcSEcCtD
Pramipexole—Cough increased—Lisinopril—dilated cardiomyopathy	0.0023	0.00439	CcSEcCtD
Pramipexole—Alopecia—Spironolactone—dilated cardiomyopathy	0.00229	0.00437	CcSEcCtD
Pramipexole—Oliguria—Lisinopril—dilated cardiomyopathy	0.00228	0.00436	CcSEcCtD
Pramipexole—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00228	0.00435	CcSEcCtD
Pramipexole—Deafness—Furosemide—dilated cardiomyopathy	0.00228	0.00435	CcSEcCtD
Pramipexole—Gout—Lisinopril—dilated cardiomyopathy	0.00225	0.00431	CcSEcCtD
Pramipexole—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00224	0.00428	CcSEcCtD
Pramipexole—ADRA2C—heart—dilated cardiomyopathy	0.0022	0.0225	CbGeAlD
Pramipexole—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00217	0.00414	CcSEcCtD
Pramipexole—Thirst—Furosemide—dilated cardiomyopathy	0.00214	0.00409	CcSEcCtD
Pramipexole—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00213	0.00407	CcSEcCtD
Pramipexole—Neck pain—Lisinopril—dilated cardiomyopathy	0.00213	0.00407	CcSEcCtD
Pramipexole—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.00213	0.00407	CcSEcCtD
Pramipexole—Purpura—Furosemide—dilated cardiomyopathy	0.00211	0.00404	CcSEcCtD
Pramipexole—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.0021	0.00402	CcSEcCtD
Pramipexole—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00209	0.004	CcSEcCtD
Pramipexole—Lethargy—Furosemide—dilated cardiomyopathy	0.00208	0.00397	CcSEcCtD
Pramipexole—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00206	0.00393	CcSEcCtD
Pramipexole—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00204	0.00391	CcSEcCtD
Pramipexole—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.00204	0.00391	CcSEcCtD
Pramipexole—Wheezing—Lisinopril—dilated cardiomyopathy	0.00204	0.00391	CcSEcCtD
Pramipexole—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00204	0.00391	CcSEcCtD
Pramipexole—Malaise—Spironolactone—dilated cardiomyopathy	0.00203	0.00388	CcSEcCtD
Pramipexole—Cystitis—Lisinopril—dilated cardiomyopathy	0.00203	0.00388	CcSEcCtD
Pramipexole—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00202	0.00385	CcSEcCtD
Pramipexole—Fluid retention—Lisinopril—dilated cardiomyopathy	0.002	0.00382	CcSEcCtD
Pramipexole—Photophobia—Lisinopril—dilated cardiomyopathy	0.00198	0.00378	CcSEcCtD
Pramipexole—Neuropathy—Lisinopril—dilated cardiomyopathy	0.00198	0.00378	CcSEcCtD
Pramipexole—Irritability—Furosemide—dilated cardiomyopathy	0.00194	0.00371	CcSEcCtD
Pramipexole—Urinary retention—Furosemide—dilated cardiomyopathy	0.00194	0.0037	CcSEcCtD
Pramipexole—Bladder pain—Lisinopril—dilated cardiomyopathy	0.0019	0.00364	CcSEcCtD
Pramipexole—Discomfort—Spironolactone—dilated cardiomyopathy	0.0019	0.00362	CcSEcCtD
Pramipexole—Dehydration—Furosemide—dilated cardiomyopathy	0.00189	0.00362	CcSEcCtD
Pramipexole—ADRA2C—cardiac atrium—dilated cardiomyopathy	0.00188	0.0192	CbGeAlD
Pramipexole—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.00187	0.00358	CcSEcCtD
Pramipexole—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00186	0.00355	CcSEcCtD
Pramipexole—Confusional state—Spironolactone—dilated cardiomyopathy	0.00185	0.00354	CcSEcCtD
Pramipexole—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00185	0.00354	CcSEcCtD
Pramipexole—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00184	0.00352	CcSEcCtD
Pramipexole—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00183	0.0035	CcSEcCtD
Pramipexole—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.0018	0.00344	CcSEcCtD
Pramipexole—Muscular weakness—Furosemide—dilated cardiomyopathy	0.0018	0.00343	CcSEcCtD
Pramipexole—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00177	0.00338	CcSEcCtD
Pramipexole—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00176	0.00337	CcSEcCtD
Pramipexole—ADRA2A—heart—dilated cardiomyopathy	0.00176	0.0179	CbGeAlD
Pramipexole—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00176	0.00336	CcSEcCtD
Pramipexole—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00172	0.0033	CcSEcCtD
Pramipexole—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00172	0.00329	CcSEcCtD
Pramipexole—Eczema—Lisinopril—dilated cardiomyopathy	0.0017	0.00325	CcSEcCtD
Pramipexole—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00168	0.0032	CcSEcCtD
Pramipexole—Injury—Lisinopril—dilated cardiomyopathy	0.00166	0.00318	CcSEcCtD
Pramipexole—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00165	0.00315	CcSEcCtD
Pramipexole—Somnolence—Spironolactone—dilated cardiomyopathy	0.00163	0.00312	CcSEcCtD
Pramipexole—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00163	0.00311	CcSEcCtD
Pramipexole—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00161	0.00308	CcSEcCtD
Pramipexole—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00161	0.00307	CcSEcCtD
Pramipexole—Renal impairment—Lisinopril—dilated cardiomyopathy	0.0016	0.00307	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00159	0.00303	CcSEcCtD
Pramipexole—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00159	0.00303	CcSEcCtD
Pramipexole—Arthritis—Lisinopril—dilated cardiomyopathy	0.00157	0.003	CcSEcCtD
Pramipexole—Drowsiness—Furosemide—dilated cardiomyopathy	0.00157	0.003	CcSEcCtD
Pramipexole—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00156	0.00299	CcSEcCtD
Pramipexole—Renal failure—Furosemide—dilated cardiomyopathy	0.00154	0.00295	CcSEcCtD
Pramipexole—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00153	0.00293	CcSEcCtD
Pramipexole—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00153	0.00292	CcSEcCtD
Pramipexole—Diplopia—Lisinopril—dilated cardiomyopathy	0.00153	0.00292	CcSEcCtD
Pramipexole—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00153	0.00292	CcSEcCtD
Pramipexole—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00152	0.0029	CcSEcCtD
Pramipexole—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00152	0.0029	CcSEcCtD
Pramipexole—Sweating—Furosemide—dilated cardiomyopathy	0.0015	0.00287	CcSEcCtD
Pramipexole—ADRA2A—cardiac atrium—dilated cardiomyopathy	0.0015	0.0153	CbGeAlD
Pramipexole—HTR2A—heart—dilated cardiomyopathy	0.00149	0.0152	CbGeAlD
Pramipexole—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00148	0.00284	CcSEcCtD
Pramipexole—Face oedema—Lisinopril—dilated cardiomyopathy	0.00147	0.00282	CcSEcCtD
Pramipexole—Urticaria—Spironolactone—dilated cardiomyopathy	0.00146	0.00279	CcSEcCtD
Pramipexole—Irritability—Lisinopril—dilated cardiomyopathy	0.00146	0.00279	CcSEcCtD
Pramipexole—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00145	0.00278	CcSEcCtD
Pramipexole—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00145	0.00278	CcSEcCtD
Pramipexole—Ataxia—Lisinopril—dilated cardiomyopathy	0.00144	0.00274	CcSEcCtD
Pramipexole—Dehydration—Lisinopril—dilated cardiomyopathy	0.00142	0.00271	CcSEcCtD
Pramipexole—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00139	0.00267	CcSEcCtD
Pramipexole—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00139	0.00266	CcSEcCtD
Pramipexole—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00138	0.00264	CcSEcCtD
Pramipexole—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00138	0.00264	CcSEcCtD
Pramipexole—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00138	0.00263	CcSEcCtD
Pramipexole—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00137	0.00261	CcSEcCtD
Pramipexole—Visual impairment—Furosemide—dilated cardiomyopathy	0.00136	0.00259	CcSEcCtD
Pramipexole—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00135	0.00259	CcSEcCtD
Pramipexole—Gastritis—Lisinopril—dilated cardiomyopathy	0.00135	0.00258	CcSEcCtD
Pramipexole—Asthma—Lisinopril—dilated cardiomyopathy	0.00132	0.00252	CcSEcCtD
Pramipexole—Influenza—Lisinopril—dilated cardiomyopathy	0.00132	0.00252	CcSEcCtD
Pramipexole—Eye disorder—Furosemide—dilated cardiomyopathy	0.00132	0.00252	CcSEcCtD
Pramipexole—Tinnitus—Furosemide—dilated cardiomyopathy	0.00131	0.00251	CcSEcCtD
Pramipexole—Pruritus—Spironolactone—dilated cardiomyopathy	0.0013	0.00249	CcSEcCtD
Pramipexole—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00129	0.00247	CcSEcCtD
Pramipexole—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00129	0.00246	CcSEcCtD
Pramipexole—Angiopathy—Furosemide—dilated cardiomyopathy	0.00128	0.00244	CcSEcCtD
Pramipexole—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00127	0.00243	CcSEcCtD
Pramipexole—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00127	0.00243	CcSEcCtD
Pramipexole—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00126	0.0024	CcSEcCtD
Pramipexole—Dysuria—Lisinopril—dilated cardiomyopathy	0.00123	0.00236	CcSEcCtD
Pramipexole—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00123	0.00234	CcSEcCtD
Pramipexole—Malnutrition—Furosemide—dilated cardiomyopathy	0.00123	0.00234	CcSEcCtD
Pramipexole—Erythema—Furosemide—dilated cardiomyopathy	0.00123	0.00234	CcSEcCtD
Pramipexole—Dizziness—Spironolactone—dilated cardiomyopathy	0.00122	0.00232	CcSEcCtD
Pramipexole—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00122	0.00232	CcSEcCtD
Pramipexole—Flatulence—Furosemide—dilated cardiomyopathy	0.00121	0.00231	CcSEcCtD
Pramipexole—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.0012	0.0023	CcSEcCtD
Pramipexole—Weight increased—Lisinopril—dilated cardiomyopathy	0.0012	0.0023	CcSEcCtD
Pramipexole—Dysgeusia—Furosemide—dilated cardiomyopathy	0.0012	0.00229	CcSEcCtD
Pramipexole—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00119	0.00228	CcSEcCtD
Pramipexole—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00119	0.00228	CcSEcCtD
Pramipexole—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00118	0.00226	CcSEcCtD
Pramipexole—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00118	0.00225	CcSEcCtD
Pramipexole—Depression—Lisinopril—dilated cardiomyopathy	0.00117	0.00224	CcSEcCtD
Pramipexole—Vomiting—Spironolactone—dilated cardiomyopathy	0.00117	0.00223	CcSEcCtD
Pramipexole—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00116	0.00222	CcSEcCtD
Pramipexole—Rash—Spironolactone—dilated cardiomyopathy	0.00116	0.00222	CcSEcCtD
Pramipexole—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00116	0.00221	CcSEcCtD
Pramipexole—Renal failure—Lisinopril—dilated cardiomyopathy	0.00116	0.00221	CcSEcCtD
Pramipexole—Vision blurred—Furosemide—dilated cardiomyopathy	0.00116	0.00221	CcSEcCtD
Pramipexole—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00115	0.0022	CcSEcCtD
Pramipexole—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00115	0.0022	CcSEcCtD
Pramipexole—Headache—Spironolactone—dilated cardiomyopathy	0.00115	0.0022	CcSEcCtD
Pramipexole—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00114	0.00219	CcSEcCtD
Pramipexole—Anaemia—Furosemide—dilated cardiomyopathy	0.00113	0.00217	CcSEcCtD
Pramipexole—Sweating—Lisinopril—dilated cardiomyopathy	0.00113	0.00216	CcSEcCtD
Pramipexole—Agitation—Furosemide—dilated cardiomyopathy	0.00113	0.00215	CcSEcCtD
Pramipexole—Haematuria—Lisinopril—dilated cardiomyopathy	0.00112	0.00214	CcSEcCtD
Pramipexole—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00111	0.00213	CcSEcCtD
Pramipexole—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00111	0.00212	CcSEcCtD
Pramipexole—Sinusitis—Lisinopril—dilated cardiomyopathy	0.0011	0.00211	CcSEcCtD
Pramipexole—Vertigo—Furosemide—dilated cardiomyopathy	0.0011	0.0021	CcSEcCtD
Pramipexole—Leukopenia—Furosemide—dilated cardiomyopathy	0.0011	0.0021	CcSEcCtD
Pramipexole—Nausea—Spironolactone—dilated cardiomyopathy	0.00109	0.00209	CcSEcCtD
Pramipexole—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00108	0.00206	CcSEcCtD
Pramipexole—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00106	0.00202	CcSEcCtD
Pramipexole—Hallucination—Lisinopril—dilated cardiomyopathy	0.00105	0.00201	CcSEcCtD
Pramipexole—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00105	0.002	CcSEcCtD
Pramipexole—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00104	0.00199	CcSEcCtD
Pramipexole—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00104	0.00199	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00104	0.00198	CcSEcCtD
Pramipexole—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00104	0.00198	CcSEcCtD
Pramipexole—Dry mouth—Furosemide—dilated cardiomyopathy	0.00102	0.00195	CcSEcCtD
Pramipexole—Confusional state—Furosemide—dilated cardiomyopathy	0.00101	0.00193	CcSEcCtD
Pramipexole—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000985	0.00188	CcSEcCtD
Pramipexole—Shock—Furosemide—dilated cardiomyopathy	0.000984	0.00188	CcSEcCtD
Pramipexole—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000981	0.00188	CcSEcCtD
Pramipexole—Flushing—Lisinopril—dilated cardiomyopathy	0.000981	0.00187	CcSEcCtD
Pramipexole—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00098	0.00187	CcSEcCtD
Pramipexole—Skin disorder—Furosemide—dilated cardiomyopathy	0.000972	0.00186	CcSEcCtD
Pramipexole—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000967	0.00185	CcSEcCtD
Pramipexole—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000959	0.00183	CcSEcCtD
Pramipexole—Anorexia—Furosemide—dilated cardiomyopathy	0.000954	0.00182	CcSEcCtD
Pramipexole—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000952	0.00182	CcSEcCtD
Pramipexole—Chills—Lisinopril—dilated cardiomyopathy	0.000948	0.00181	CcSEcCtD
Pramipexole—Hypotension—Furosemide—dilated cardiomyopathy	0.000935	0.00179	CcSEcCtD
Pramipexole—Alopecia—Lisinopril—dilated cardiomyopathy	0.000934	0.00178	CcSEcCtD
Pramipexole—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000926	0.00177	CcSEcCtD
Pramipexole—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00092	0.00176	CcSEcCtD
Pramipexole—Erythema—Lisinopril—dilated cardiomyopathy	0.00092	0.00176	CcSEcCtD
Pramipexole—Flatulence—Lisinopril—dilated cardiomyopathy	0.000906	0.00173	CcSEcCtD
Pramipexole—Tension—Lisinopril—dilated cardiomyopathy	0.000903	0.00172	CcSEcCtD
Pramipexole—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000901	0.00172	CcSEcCtD
Pramipexole—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000898	0.00172	CcSEcCtD
Pramipexole—Nervousness—Lisinopril—dilated cardiomyopathy	0.000893	0.00171	CcSEcCtD
Pramipexole—Back pain—Lisinopril—dilated cardiomyopathy	0.00089	0.0017	CcSEcCtD
Pramipexole—Somnolence—Furosemide—dilated cardiomyopathy	0.000889	0.0017	CcSEcCtD
Pramipexole—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000884	0.00169	CcSEcCtD
Pramipexole—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00087	0.00166	CcSEcCtD
Pramipexole—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000867	0.00166	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000864	0.00165	CcSEcCtD
Pramipexole—Fatigue—Furosemide—dilated cardiomyopathy	0.000863	0.00165	CcSEcCtD
Pramipexole—Tremor—Lisinopril—dilated cardiomyopathy	0.000862	0.00165	CcSEcCtD
Pramipexole—Constipation—Furosemide—dilated cardiomyopathy	0.000856	0.00164	CcSEcCtD
Pramipexole—Pain—Furosemide—dilated cardiomyopathy	0.000856	0.00164	CcSEcCtD
Pramipexole—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000853	0.00163	CcSEcCtD
Pramipexole—Anaemia—Lisinopril—dilated cardiomyopathy	0.00085	0.00162	CcSEcCtD
Pramipexole—Malaise—Lisinopril—dilated cardiomyopathy	0.000829	0.00159	CcSEcCtD
Pramipexole—Vertigo—Lisinopril—dilated cardiomyopathy	0.000826	0.00158	CcSEcCtD
Pramipexole—Syncope—Lisinopril—dilated cardiomyopathy	0.000825	0.00158	CcSEcCtD
Pramipexole—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000824	0.00158	CcSEcCtD
Pramipexole—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000823	0.00157	CcSEcCtD
Pramipexole—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000818	0.00156	CcSEcCtD
Pramipexole—Palpitations—Lisinopril—dilated cardiomyopathy	0.000813	0.00155	CcSEcCtD
Pramipexole—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000808	0.00154	CcSEcCtD
Pramipexole—Cough—Lisinopril—dilated cardiomyopathy	0.000803	0.00153	CcSEcCtD
Pramipexole—Urticaria—Furosemide—dilated cardiomyopathy	0.000795	0.00152	CcSEcCtD
Pramipexole—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000791	0.00151	CcSEcCtD
Pramipexole—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000791	0.00151	CcSEcCtD
Pramipexole—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000783	0.0015	CcSEcCtD
Pramipexole—Chest pain—Lisinopril—dilated cardiomyopathy	0.000783	0.0015	CcSEcCtD
Pramipexole—Myalgia—Lisinopril—dilated cardiomyopathy	0.000783	0.0015	CcSEcCtD
Pramipexole—Anxiety—Lisinopril—dilated cardiomyopathy	0.00078	0.00149	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000778	0.00149	CcSEcCtD
Pramipexole—Discomfort—Lisinopril—dilated cardiomyopathy	0.000774	0.00148	CcSEcCtD
Pramipexole—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000766	0.00146	CcSEcCtD
Pramipexole—Confusional state—Lisinopril—dilated cardiomyopathy	0.000757	0.00145	CcSEcCtD
Pramipexole—Oedema—Lisinopril—dilated cardiomyopathy	0.000751	0.00143	CcSEcCtD
Pramipexole—Infection—Lisinopril—dilated cardiomyopathy	0.000746	0.00143	CcSEcCtD
Pramipexole—Shock—Lisinopril—dilated cardiomyopathy	0.000738	0.00141	CcSEcCtD
Pramipexole—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000737	0.00141	CcSEcCtD
Pramipexole—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000735	0.0014	CcSEcCtD
Pramipexole—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000733	0.0014	CcSEcCtD
Pramipexole—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000729	0.00139	CcSEcCtD
Pramipexole—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000726	0.00139	CcSEcCtD
Pramipexole—Asthenia—Furosemide—dilated cardiomyopathy	0.000718	0.00137	CcSEcCtD
Pramipexole—Anorexia—Lisinopril—dilated cardiomyopathy	0.000716	0.00137	CcSEcCtD
Pramipexole—Pruritus—Furosemide—dilated cardiomyopathy	0.000708	0.00135	CcSEcCtD
Pramipexole—Hypotension—Lisinopril—dilated cardiomyopathy	0.000701	0.00134	CcSEcCtD
Pramipexole—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000684	0.00131	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000684	0.00131	CcSEcCtD
Pramipexole—Insomnia—Lisinopril—dilated cardiomyopathy	0.000679	0.0013	CcSEcCtD
Pramipexole—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000674	0.00129	CcSEcCtD
Pramipexole—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000669	0.00128	CcSEcCtD
Pramipexole—Somnolence—Lisinopril—dilated cardiomyopathy	0.000667	0.00128	CcSEcCtD
Pramipexole—Dizziness—Furosemide—dilated cardiomyopathy	0.000662	0.00126	CcSEcCtD
Pramipexole—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000661	0.00126	CcSEcCtD
Pramipexole—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000653	0.00125	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000648	0.00124	CcSEcCtD
Pramipexole—Fatigue—Lisinopril—dilated cardiomyopathy	0.000647	0.00124	CcSEcCtD
Pramipexole—Pain—Lisinopril—dilated cardiomyopathy	0.000642	0.00123	CcSEcCtD
Pramipexole—Constipation—Lisinopril—dilated cardiomyopathy	0.000642	0.00123	CcSEcCtD
Pramipexole—Vomiting—Furosemide—dilated cardiomyopathy	0.000636	0.00122	CcSEcCtD
Pramipexole—Rash—Furosemide—dilated cardiomyopathy	0.000631	0.00121	CcSEcCtD
Pramipexole—Dermatitis—Furosemide—dilated cardiomyopathy	0.00063	0.0012	CcSEcCtD
Pramipexole—Headache—Furosemide—dilated cardiomyopathy	0.000627	0.0012	CcSEcCtD
Pramipexole—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000619	0.00118	CcSEcCtD
Pramipexole—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000614	0.00117	CcSEcCtD
Pramipexole—Urticaria—Lisinopril—dilated cardiomyopathy	0.000596	0.00114	CcSEcCtD
Pramipexole—Nausea—Furosemide—dilated cardiomyopathy	0.000594	0.00114	CcSEcCtD
Pramipexole—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000593	0.00113	CcSEcCtD
Pramipexole—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000593	0.00113	CcSEcCtD
Pramipexole—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000553	0.00106	CcSEcCtD
Pramipexole—Asthenia—Lisinopril—dilated cardiomyopathy	0.000539	0.00103	CcSEcCtD
Pramipexole—Pruritus—Lisinopril—dilated cardiomyopathy	0.000531	0.00101	CcSEcCtD
Pramipexole—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000514	0.000982	CcSEcCtD
Pramipexole—Dizziness—Lisinopril—dilated cardiomyopathy	0.000496	0.000949	CcSEcCtD
Pramipexole—Vomiting—Lisinopril—dilated cardiomyopathy	0.000477	0.000912	CcSEcCtD
Pramipexole—Rash—Lisinopril—dilated cardiomyopathy	0.000473	0.000905	CcSEcCtD
Pramipexole—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000473	0.000904	CcSEcCtD
Pramipexole—Headache—Lisinopril—dilated cardiomyopathy	0.00047	0.000899	CcSEcCtD
Pramipexole—Nausea—Lisinopril—dilated cardiomyopathy	0.000446	0.000852	CcSEcCtD
Pramipexole—HTR2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	9.82e-05	0.000259	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	9.81e-05	0.000259	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	9.79e-05	0.000259	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	9.78e-05	0.000258	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—CXCL2—dilated cardiomyopathy	9.78e-05	0.000258	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—ADRB2—dilated cardiomyopathy	9.74e-05	0.000257	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—AGT—dilated cardiomyopathy	9.74e-05	0.000257	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	9.74e-05	0.000257	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.68e-05	0.000255	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	9.61e-05	0.000254	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.57e-05	0.000253	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—AGT—dilated cardiomyopathy	9.54e-05	0.000252	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.52e-05	0.000251	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	9.5e-05	0.000251	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—ADRB2—dilated cardiomyopathy	9.48e-05	0.00025	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	9.47e-05	0.00025	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—AGT—dilated cardiomyopathy	9.38e-05	0.000248	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	9.38e-05	0.000248	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.37e-05	0.000247	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	9.32e-05	0.000246	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—AGT—dilated cardiomyopathy	9.3e-05	0.000246	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—PSEN2—dilated cardiomyopathy	9.25e-05	0.000244	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.22e-05	0.000243	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CXCL2—dilated cardiomyopathy	9.22e-05	0.000243	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—AGTR2—dilated cardiomyopathy	9.22e-05	0.000243	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—AGT—dilated cardiomyopathy	9.18e-05	0.000242	CbGpPWpGaD
Pramipexole—ADRA2B—Hemostasis—RAF1—dilated cardiomyopathy	9.1e-05	0.00024	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—AGTR2—dilated cardiomyopathy	9.1e-05	0.00024	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CXCL2—dilated cardiomyopathy	9.1e-05	0.00024	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.09e-05	0.00024	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	9.06e-05	0.000239	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—AGT—dilated cardiomyopathy	8.96e-05	0.000236	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	8.94e-05	0.000236	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.93e-05	0.000236	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	8.92e-05	0.000235	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.89e-05	0.000235	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—RAC1—dilated cardiomyopathy	8.84e-05	0.000233	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.82e-05	0.000233	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	8.81e-05	0.000232	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—RAC1—dilated cardiomyopathy	8.72e-05	0.00023	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.7e-05	0.00023	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	8.67e-05	0.000229	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.64e-05	0.000228	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.6e-05	0.000227	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CXCR3—dilated cardiomyopathy	8.57e-05	0.000226	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—RAF1—dilated cardiomyopathy	8.5e-05	0.000224	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	8.48e-05	0.000224	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.46e-05	0.000223	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CXCR3—dilated cardiomyopathy	8.46e-05	0.000223	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—AGT—dilated cardiomyopathy	8.45e-05	0.000223	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	8.37e-05	0.000221	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—AGT—dilated cardiomyopathy	8.34e-05	0.00022	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	8.33e-05	0.00022	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—ADRB1—dilated cardiomyopathy	8.3e-05	0.000219	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—AGT—dilated cardiomyopathy	8.29e-05	0.000219	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CXCL2—dilated cardiomyopathy	8.22e-05	0.000217	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	8.22e-05	0.000217	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—ADRB1—dilated cardiomyopathy	8.19e-05	0.000216	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.18e-05	0.000216	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	8.11e-05	0.000214	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	8.1e-05	0.000214	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.01e-05	0.000211	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	8e-05	0.000211	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.96e-05	0.00021	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.93e-05	0.000209	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.93e-05	0.000209	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.89e-05	0.000208	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.89e-05	0.000208	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.88e-05	0.000208	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.88e-05	0.000208	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—RAC1—dilated cardiomyopathy	7.86e-05	0.000208	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.84e-05	0.000207	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.76e-05	0.000205	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.74e-05	0.000204	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.72e-05	0.000204	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	7.7e-05	0.000203	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.67e-05	0.000203	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.67e-05	0.000203	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.64e-05	0.000202	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.6e-05	0.000201	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.59e-05	0.0002	CbGpPWpGaD
Pramipexole—SLC22A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	7.57e-05	0.0002	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.56e-05	0.0002	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—AGT—dilated cardiomyopathy	7.53e-05	0.000199	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.52e-05	0.000199	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—AGT—dilated cardiomyopathy	7.51e-05	0.000198	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.47e-05	0.000197	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.4e-05	0.000195	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.37e-05	0.000195	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.36e-05	0.000194	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.35e-05	0.000194	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.34e-05	0.000194	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	7.26e-05	0.000192	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.23e-05	0.000191	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—AGT—dilated cardiomyopathy	7.23e-05	0.000191	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.14e-05	0.000188	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.13e-05	0.000188	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.13e-05	0.000188	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.1e-05	0.000188	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.09e-05	0.000187	CbGpPWpGaD
Pramipexole—SLC22A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	7.05e-05	0.000186	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—AGT—dilated cardiomyopathy	7.03e-05	0.000186	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.02e-05	0.000185	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.02e-05	0.000185	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—AGTR1—dilated cardiomyopathy	7e-05	0.000185	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.96e-05	0.000184	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.96e-05	0.000184	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.91e-05	0.000182	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.91e-05	0.000182	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	6.9e-05	0.000182	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.85e-05	0.000181	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.85e-05	0.000181	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.76e-05	0.000178	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.73e-05	0.000178	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.68e-05	0.000176	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.67e-05	0.000176	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.64e-05	0.000175	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.62e-05	0.000175	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	6.58e-05	0.000174	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.57e-05	0.000173	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.53e-05	0.000172	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.51e-05	0.000172	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.47e-05	0.000171	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.42e-05	0.00017	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	6.38e-05	0.000168	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.37e-05	0.000168	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.32e-05	0.000167	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.29e-05	0.000166	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	6.28e-05	0.000166	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.27e-05	0.000166	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.23e-05	0.000165	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.23e-05	0.000165	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.22e-05	0.000164	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.17e-05	0.000163	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.13e-05	0.000162	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.1e-05	0.000161	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.07e-05	0.00016	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.05e-05	0.00016	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—RAC1—dilated cardiomyopathy	6.02e-05	0.000159	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.99e-05	0.000158	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.98e-05	0.000158	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.9e-05	0.000156	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—RAC1—dilated cardiomyopathy	5.9e-05	0.000156	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.86e-05	0.000155	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—GPX1—dilated cardiomyopathy	5.82e-05	0.000154	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—RAC1—dilated cardiomyopathy	5.8e-05	0.000153	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.79e-05	0.000153	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.79e-05	0.000153	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.78e-05	0.000153	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.78e-05	0.000153	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.76e-05	0.000152	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—AGT—dilated cardiomyopathy	5.75e-05	0.000152	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	5.71e-05	0.000151	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.7e-05	0.000151	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—CD36—dilated cardiomyopathy	5.67e-05	0.00015	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—GPX1—dilated cardiomyopathy	5.66e-05	0.00015	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—AGT—dilated cardiomyopathy	5.63e-05	0.000149	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.61e-05	0.000148	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.6e-05	0.000148	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—AGT—dilated cardiomyopathy	5.54e-05	0.000146	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—RAC1—dilated cardiomyopathy	5.54e-05	0.000146	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—CD36—dilated cardiomyopathy	5.52e-05	0.000146	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—GPX1—dilated cardiomyopathy	5.43e-05	0.000143	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.35e-05	0.000141	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—AGT—dilated cardiomyopathy	5.29e-05	0.00014	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—CD36—dilated cardiomyopathy	5.29e-05	0.00014	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.27e-05	0.000139	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—RAC1—dilated cardiomyopathy	5.22e-05	0.000138	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.22e-05	0.000138	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—RAF1—dilated cardiomyopathy	5.21e-05	0.000138	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—RAC1—dilated cardiomyopathy	5.15e-05	0.000136	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.15e-05	0.000136	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—AGT—dilated cardiomyopathy	5.11e-05	0.000135	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.08e-05	0.000134	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.04e-05	0.000133	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.02e-05	0.000132	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	5e-05	0.000132	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—AGT—dilated cardiomyopathy	4.99e-05	0.000132	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.97e-05	0.000131	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—AGT—dilated cardiomyopathy	4.97e-05	0.000131	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.95e-05	0.000131	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—AGT—dilated cardiomyopathy	4.92e-05	0.00013	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.88e-05	0.000129	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.81e-05	0.000127	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.79e-05	0.000127	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—AGT—dilated cardiomyopathy	4.76e-05	0.000126	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—RAC1—dilated cardiomyopathy	4.65e-05	0.000123	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.64e-05	0.000122	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	4.6e-05	0.000121	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.55e-05	0.00012	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.54e-05	0.00012	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	4.49e-05	0.000119	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	4.48e-05	0.000118	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—RAC1—dilated cardiomyopathy	4.47e-05	0.000118	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.47e-05	0.000118	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—AGT—dilated cardiomyopathy	4.45e-05	0.000117	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.43e-05	0.000117	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.36e-05	0.000115	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.36e-05	0.000115	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—RAC1—dilated cardiomyopathy	4.35e-05	0.000115	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.29e-05	0.000113	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	4.29e-05	0.000113	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—AGT—dilated cardiomyopathy	4.27e-05	0.000113	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.26e-05	0.000113	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—AGT—dilated cardiomyopathy	4.15e-05	0.00011	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	4.03e-05	0.000106	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.02e-05	0.000106	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—RAF1—dilated cardiomyopathy	3.99e-05	0.000105	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.97e-05	0.000105	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.96e-05	0.000105	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	3.94e-05	0.000104	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—RAF1—dilated cardiomyopathy	3.91e-05	0.000103	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.91e-05	0.000103	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	3.88e-05	0.000102	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—RAF1—dilated cardiomyopathy	3.85e-05	0.000102	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	3.77e-05	9.95e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	3.71e-05	9.79e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—RAF1—dilated cardiomyopathy	3.67e-05	9.69e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.58e-05	9.45e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—EGFR—dilated cardiomyopathy	3.57e-05	9.44e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	3.53e-05	9.32e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	3.46e-05	9.14e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.46e-05	9.13e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.44e-05	9.08e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—RAF1—dilated cardiomyopathy	3.42e-05	9.02e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	3.37e-05	8.9e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.35e-05	8.83e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—RAF1—dilated cardiomyopathy	3.09e-05	8.14e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.04e-05	8.01e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.99e-05	7.88e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	2.98e-05	7.86e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—RAF1—dilated cardiomyopathy	2.96e-05	7.82e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—RAF1—dilated cardiomyopathy	2.88e-05	7.61e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—EGFR—dilated cardiomyopathy	2.74e-05	7.23e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.72e-05	7.17e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—EGFR—dilated cardiomyopathy	2.68e-05	7.08e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—EGFR—dilated cardiomyopathy	2.64e-05	6.96e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	2.61e-05	6.9e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	2.57e-05	6.79e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—EGFR—dilated cardiomyopathy	2.52e-05	6.65e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.38e-05	6.27e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—EGFR—dilated cardiomyopathy	2.34e-05	6.19e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	2.34e-05	6.18e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—EGFR—dilated cardiomyopathy	2.12e-05	5.58e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	2.04e-05	5.39e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—EGFR—dilated cardiomyopathy	2.03e-05	5.36e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—EGFR—dilated cardiomyopathy	1.98e-05	5.22e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	1.79e-05	4.73e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.76e-05	4.66e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.61e-05	4.24e-05	CbGpPWpGaD
